397 related articles for article (PubMed ID: 19325845)
21. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
[TBL] [Abstract][Full Text] [Related]
22. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells.
Syed DN; Afaq F; Kweon MH; Hadi N; Bhatia N; Spiegelman VS; Mukhtar H
Oncogene; 2007 Feb; 26(5):673-82. PubMed ID: 16862172
[TBL] [Abstract][Full Text] [Related]
23. Green tea (-)-epigallocatechin gallate inhibits the growth of human villous trophoblasts via the ERK, p38, AMP-activated protein kinase, and protein kinase B pathways.
Shih LJ; Chen TF; Lin CK; Liu HS; Kao YH
Am J Physiol Cell Physiol; 2016 Aug; 311(2):C308-21. PubMed ID: 27147558
[TBL] [Abstract][Full Text] [Related]
24. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death.
Chen C; Yu R; Owuor ED; Kong AN
Arch Pharm Res; 2000 Dec; 23(6):605-12. PubMed ID: 11156183
[TBL] [Abstract][Full Text] [Related]
25. Molecular targets for green tea in prostate cancer prevention.
Adhami VM; Ahmad N; Mukhtar H
J Nutr; 2003 Jul; 133(7 Suppl):2417S-2424S. PubMed ID: 12840218
[TBL] [Abstract][Full Text] [Related]
26. Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma.
Spinella F; Rosanò L; Di Castro V; Decandia S; Albini A; Nicotra MR; Natali PG; Bagnato A
Mol Cancer Ther; 2006 Jun; 5(6):1483-92. PubMed ID: 16818507
[TBL] [Abstract][Full Text] [Related]
27. Molecular insights into the differences in anti-inflammatory activities of green tea catechins on IL-1β signaling in rheumatoid arthritis synovial fibroblasts.
Fechtner S; Singh A; Chourasia M; Ahmed S
Toxicol Appl Pharmacol; 2017 Aug; 329():112-120. PubMed ID: 28532672
[TBL] [Abstract][Full Text] [Related]
28. Green tea (-)-epigallocatechin gallate induced growth inhibition of human placental choriocarcinoma cells.
Shih LJ; Lin YR; Lin CK; Liu HS; Kao YH
Placenta; 2016 May; 41():1-9. PubMed ID: 27208402
[TBL] [Abstract][Full Text] [Related]
29. Green tea (-)-epigallocatechin gallate inhibits IGF-I and IGF-II stimulation of 3T3-L1 preadipocyte mitogenesis via the 67-kDa laminin receptor, but not AMP-activated protein kinase pathway.
Ku HC; Liu HS; Hung PF; Chen CL; Liu HC; Chang HH; Tsuei YW; Shih LJ; Lin CL; Lin CM; Kao YH
Mol Nutr Food Res; 2012 Apr; 56(4):580-92. PubMed ID: 22495985
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of resistance to EGFR tyrosine kinase inhibitors.
Huang L; Fu L
Acta Pharm Sin B; 2015 Sep; 5(5):390-401. PubMed ID: 26579470
[TBL] [Abstract][Full Text] [Related]
31. The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cells growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling.
Zhu W; Li MC; Wang FR; Mackenzie GG; Oteiza PI
Biochem Pharmacol; 2020 May; 175():113923. PubMed ID: 32217102
[TBL] [Abstract][Full Text] [Related]
32. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells.
Shimizu M; Shirakami Y; Sakai H; Tatebe H; Nakagawa T; Hara Y; Weinstein IB; Moriwaki H
Cancer Lett; 2008 Apr; 262(1):10-8. PubMed ID: 18164805
[TBL] [Abstract][Full Text] [Related]
33. Preclinical Pharmacological Activities of Epigallocatechin-3-gallate in Signaling Pathways: An Update on Cancer.
Sharifi-Rad M; Pezzani R; Redaelli M; Zorzan M; Imran M; Ahmed Khalil A; Salehi B; Sharopov F; Cho WC; Sharifi-Rad J
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979082
[TBL] [Abstract][Full Text] [Related]
34. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.
Rodriguez SK; Guo W; Liu L; Band MA; Paulson EK; Meydani M
Int J Cancer; 2006 Apr; 118(7):1635-44. PubMed ID: 16217757
[TBL] [Abstract][Full Text] [Related]
35. The epigallocatechin gallate derivative Y
Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
[TBL] [Abstract][Full Text] [Related]
36. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines.
Masuda M; Suzui M; Weinstein IB
Clin Cancer Res; 2001 Dec; 7(12):4220-9. PubMed ID: 11751523
[TBL] [Abstract][Full Text] [Related]
37. Epigallocatechin gallate targeting of membrane type 1 matrix metalloproteinase-mediated Src and Janus kinase/signal transducers and activators of transcription 3 signaling inhibits transcription of colony-stimulating factors 2 and 3 in mesenchymal stromal cells.
Zgheib A; Lamy S; Annabi B
J Biol Chem; 2013 May; 288(19):13378-86. PubMed ID: 23548906
[TBL] [Abstract][Full Text] [Related]
38. Green tea (-)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met.
Koh YW; Choi EC; Kang SU; Hwang HS; Lee MH; Pyun J; Park R; Lee Y; Kim CH
J Nutr Biochem; 2011 Nov; 22(11):1074-83. PubMed ID: 21292466
[TBL] [Abstract][Full Text] [Related]
39. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents.
Agarwal R
Biochem Pharmacol; 2000 Oct; 60(8):1051-9. PubMed ID: 11007941
[TBL] [Abstract][Full Text] [Related]
40. Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn.
Kim JA; Formoso G; Li Y; Potenza MA; Marasciulo FL; Montagnani M; Quon MJ
J Biol Chem; 2007 May; 282(18):13736-45. PubMed ID: 17363366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
